Sejahteraraya Anugrahjaya Tbk

Sejahteraraya Anugrahjaya Tbk

SRAJ · JK · Healthcare / Medical Care Facilities

10,475.00IDR+550.00 (+5.54%)

Price History

Full chart

Market Stats

Previous Close9,925.00
Open10,475.00
Day Range10,475.00 – 10,475.00
52-Week Range8,525.00 – 19,200.00
Volume700
Market Cap126.67T
P/E (TTM)0.00
Forward P/E0.00
EPS-37.52
Dividend Yield0.00%
Beta0.69
50-Day Avg12,474.50
200-Day Avg13,462.25

About

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. The company manages and operates hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, liver center, oncology center, orthopedic center, spine and arthroplasty center, obstetrics and gynecology center, internal medicine and pulmonology, pediatric center, aesthetic center, sports injury treatment and performance center, rehabilitation center, and immunology center. The company was formerly known as PT Sejahtera Raya Anugrah and changed its name to PT Sejahteraraya Anugrahjaya Tbk in December 1992. PT Sejahteraraya Anugrahjaya Tbk was founded in 1991 and is based in Tangerang, Indonesia. PT Sejahteraraya Anugrahjaya Tbk is a subsidiary of PT Surya Cipta Inti Cemerlang.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Navin Sonthalia
  • Employees4.94K
  • HeadquartersJI. Honoris Raya Kav. 6, Tangerang, Indonesia, 15117, Indonesia
  • Websitehttps://www.mayapadahospital.com

Leadership

  • Mr. Navin SonthaliaPresident Director · b. 1970
  • Ms. Victoria TahirDirector of Finance · b. 1978
  • Mr. Arif MualimOperational Director · b. 1969
  • Mr. Handoko GunawanHead of Internal Audit · b. 1958
  • Arie FarisandiCorporate Secretary · b. 1982

Financials

Income Statement

Currency: IDR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue122.18B149.18B167.48B194.50B221.47B340.52B449.07B576.18B631.68B806.03B1.00T1.28T1.92T1.93T2.50T3.15T2.59T
Growth (%)-+22.10%+12.27%+16.13%+13.87%+53.75%+31.88%+28.31%+9.63%+27.60%+24.31%+28.12%+49.90%+0.50%+29.42%+25.77%-17.75%
Cost of Revenue73.30B80.24B88.27B104.02B151.90B316.23B392.91B467.46B519.80B618.69B721.72B864.70B1.22T1.38T1.81T2.23T1.63T
Gross Profit-68.94B79.21B90.48B69.58B24.29B56.16B108.72B111.88B187.34B280.29B419.10B705.03B557.05B689.33B916.44B958.28B
Gross Margin-46.21%47.29%46.52%31.42%7.13%12.51%18.87%17.71%23.24%27.97%32.65%36.64%28.80%27.54%29.11%37.01%
Operating Expense-60.63B73.33B71.13B117.66B107.46B133.11B184.70B192.07B265.59B320.02B403.25B478.55B526.04B583.07B733.93B854.93B
Operating Income10.74B8.31B5.88B19.35B-48.08B-83.17B-76.95B-75.98B-80.19B-78.24B-39.73B15.85B226.48B31.01B106.26B182.52B103.36B
Operating Margin8.79%5.57%3.51%9.95%-21.71%-24.42%-17.14%-13.19%-12.70%-9.71%-3.97%1.23%11.77%1.60%4.25%5.80%3.99%
EBITDA-8.31B47.63B47.76B-40.16B-21.59B-22.10B7.62B3.41B-642.33M28.09B206.92B455.64B292.99B437.23B497.93B484.61B
EBITDA Margin-5.57%28.44%24.56%-18.14%-6.34%-4.92%1.32%0.54%-0.08%2.80%16.12%23.68%15.15%17.47%15.82%18.71%
Net Income4.50B6.01B4.71B4.74B-55.12B-100.36B-132.17B-97.22B-100.85B-95.42B-75.77B-14.38B165.31B-44.19B-38.49B-23.51B-199.00B
Net Income Margin3.68%4.03%2.81%2.44%-24.89%-29.47%-29.43%-16.87%-15.97%-11.84%-7.56%-1.12%8.59%-2.28%-1.54%-0.75%-7.69%
Interest Expense02.17M17.40B13.09B23.76B58.40B51.06B40.24B22.43B18.78B17.88B74.17B118.03B101.55B179.24B181.18B390.83B
Interest Expense % of Total Revenue0.00%0.00%10.39%6.73%10.73%17.15%11.37%6.98%3.55%2.33%1.78%5.78%6.13%5.25%7.16%5.75%15.09%

Balance Sheet

Currency: IDR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets646.26B728.17B864.07B1.24T2.05T1.86T1.67T2.30T2.16T2.74T3.11T4.35T4.87T5.75T5.61T5.68T7.62T
Total Liabilities151.27B171.43B214.65B582.31B806.24B712.79B656.94B579.52B531.07B896.16B1.33T2.59T2.94T3.85T3.75T3.85T6.29T
Total Equity492.49B553.74B646.42B651.09B1.24T1.14T1.01T1.72T1.62T1.84T1.78T1.75T1.93T1.89T1.86T1.83T1.33T
Cash4.64B11.07B8.37B26.47B387.50B398.98B246.44B717.38B246.24B224.62B232.12B629.61B700.92B1.12T515.18B277.21B1.85T
Total Debt104.43B152.84B194.66B524.90B432.55B388.64B325.56B196.12B93.98B135.02B251.56B1.14T846.19B1.73T3.16T1.67T4.69T
Net Debt99.79B141.77B186.29B498.42B45.06B-10.34B78.33B-521.96B-152.27B-89.60B19.44B442.64B145.27B607.19B2.65T1.39T2.84T

Cash Flow

Currency: IDR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.70B31.10B46.92B28.37B7.92B16.21B16.01B16.14B15.24B16.24B75.42B93.88B336.79B210.47B55.92B273.25B129.67B
Investing Cash Flow--132.13B-161.21B-300.43B-171.63B-42.00B-44.10B-202.69B-407.69B-383.99B-390.53B-550.71B-468.28B-678.22B-585.39B-532.32B-612.15B
Financing Cash Flow163.05B107.47B111.59B268.05B551.30B92.41B-142.36B684.31B-79.16B175.46B308.15B854.32B179.24B885.08B-73.60B21.09B2.02T
Capital Expenditure171.69B132.73B161.63B300.48B171.75B42.91B44.77B202.84B407.77B409.56B390.72B550.82B467.19B659.89B588.60B532.60B579.61B
Free Cash Flow--101.63B-114.71B-272.11B-163.84B-26.70B-28.76B-186.69B-392.53B-393.32B-315.30B-456.94B-130.40B-449.42B-532.68B-259.35B-449.94B
FCF to OCF--326.81%-244.48%-959.18%-2069.95%-164.73%-179.58%-1156.62%-2576.48%-2421.96%-418.09%-486.72%-38.72%-213.52%-952.63%-94.92%-346.98%

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate-------------------------------------------
EPS Actual0.06-5.01-2.60-2.48-2.41-8.07-2.24-4.69-3.15-2.29-2.57-3.26-7.77-1.74-4.88-5.170.06-2.24-1.61-0.51-4.88-2.23-1.89-0.88-3.160.33-0.890.36-6.10-0.79-4.460.723.335.687.255.57-4.730.74-2.74-1.03-0.66-1.15-2.34
Surprise-------------------------------------------
Timing-------------------------------------------

Key Statistics & Ratios

Market Cap126.67T
Enterprise Value130.34T
Trailing P/E0.00
Forward P/E0.00
Price / Sales46.49
Price / Book128.50
EPS-37.52
Book Value80.55
Revenue (TTM)2.72T
Gross Profit (TTM)1.04T
EBITDA270.34B
Profit Margin-16.84%
Operating Margin-3.47%
Return on Equity-37.64%
Return on Assets-0.84%
Shares Outstanding12.24B
Shares Float1.82B
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%